Baker Avenue Asset Management, LP Viatris Inc Transaction History

Baker Avenue Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $843 - $998	88 Added 10.49%	927 $9,000
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $270 - $308	-30 Reduced 3.45%	839 $8,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $653 - $870	71 Added 8.9%	869 $8,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $6,958 - $9,224	798 New	798 $8,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.